A case study to know the level of awareness about pharmacogenomics and its clinical application among doctors of Lucknow, Uttar Pradesh, India

Authors

  • Aditi Jhunjhunwala Department of Pharmacology, King George’s Medical University, Lucknow, Uttar Pradesh, India
  • Narendra Kumar Department of Pharmacology, King George’s Medical University, Lucknow, Uttar Pradesh, India
  • Rahul Kumar Department of Pharmacology, King George’s Medical University, Lucknow, Uttar Pradesh, India
  • Sarvesh Singh Department of Pharmacology, King George’s Medical University, Lucknow, Uttar Pradesh, India
  • Rakesh Kumar Dixit Department of Pharmacology, King George’s Medical University, Lucknow, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20161511

Keywords:

pharmacogenomics, Doctors, Awareness, Personalized medicine.

Abstract

Background: Presently knowledge of pharmacogenomics is important for therapeutic purposes as well as for the prevention of many ADRs (adverse drug reactions). So this study was planned to know the level of awareness about pharmacogenomics and its clinical application among doctors of Lucknow, Uttar Pradesh, India.

Methods: The study was done through a survey among 400 doctors by a questionnaire method. The questions were formulated to know the awareness and extent of knowledge of doctor. The answers were in yes and no and the data collected was calculated in percentage.

Results: 79.75% doctors were well aware about pharmacogenomics. 13.0% doctors were not aware but wanted to know about it, while 7.25% of doctors were neither aware nor interested about pharmacogenomics.

Conclusions: Most of the doctors were aware about the pharmacogenomics theoretically and they need to be updated about its clinical application in their practice by seminars, presentation and workshops.

References

Relling MV, Giacomini KM. Pharmacogenetics. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman and Gilman’s the pharmacological basis of therapeutics. 12th edi. New York: McGraw-Hill; 2011:145-68.

Johnson JA. Pharmacogenetics: potential for individualized drug therapy through genetics. Trends Genet. 2003;19(11):660-6.

Cordero P, Ashley EA. Whole-genome sequencing in personalized therapeutics. Clinical Pharmacology and Therapeutics. 2012;91:1001-9.

Squassina A, Manchia M, Manolopoulos VG, Artac M, Lappa-Manakou C, Karkabouna S, et al. Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice. Pharmacogenomics. 2010;11(8):1149-67.

Kudzi W, Adjei GO, Ofori-Adjei D, Dodoo AN. Pharmacogenetics in Ghana: reviewing the evidence. Ghana Med J. 2011;45(2):73-80.

Lesko LJ. Personalized medicine: elusive dream or imminent reality? Clin Pharmacol Ther. 2007;81(6):807-16.

Kudzi W, Addy BS, Dzudzor B. Knowledge of pharmacogenetics among healthcare professionals and faculty members of health training institutions in Ghana. Ghana Medical Journal. 2015;49(1):50-6.

Lesko LJ, Johnson JA. Academia at the crossroads: education and training in pharmacogenomics. Pers Med. 2012;9:497-506.

Stanek EJ, Sanders CL, Taber KA, Khalid M, Patel A, Verbrugge RR, et al. Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey. Clin Pharmacol Ther. 2012;91(3):450-8.

Haga SB, Burke W, Ginsburg GS, Mills R, Agans R. Primary care physicians knowledge of and experience with pharmacogenetic testing. Clin Genet. 2012;82(4):3883-94.

Downloads

Published

2016-12-30

How to Cite

Jhunjhunwala, A., Kumar, N., Kumar, R., Singh, S., & Dixit, R. K. (2016). A case study to know the level of awareness about pharmacogenomics and its clinical application among doctors of Lucknow, Uttar Pradesh, India. International Journal of Basic & Clinical Pharmacology, 5(3), 739–741. https://doi.org/10.18203/2319-2003.ijbcp20161511

Issue

Section

Original Research Articles